CHP set to bridge advocacy gap with US

businesstoday | April 29, 2019

At a time when world's largest market for pharmaceuticals, the US is sparing no words to accuse India as a source of counterfeit medicines, and complaining about India's intellectual property protection policies and drugs and medical device pricing regulatory systems, an industry veteran - Gurpreet Sandhu - is attempting to build an organisation that can bridge the advocacy gap between India and the US. Delhi based Sandhu, the managing director of privately held Reva Pharma, has taken the lead in setting up a global not for profit think tank - Council for Healthcare and Pharma (CHP). The Delhi headquartered think tank plans to open offices in the US, Japan and other countries. The Council is hitting the road running, as its first programme, Legislative Day at Capitol Hill, Washington D.C, for US Congress members and opinion makers, is on April 30.

Spotlight

Learn from our expert Jennifer Roark on the importance of Container Closure Integrity Testing.  In this short video, Roark explains why Container Closure Integrity Testing is important to the customer and the patient.


Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More